Patents-Review.com
🔗 Permalink
Assignee profile:

Wyeth LLC

City:

Madison, New Jersey

Country:

United States

Published Applications:

429

Last publication date:

2023-12-28

Patent Grants:

326

Last grant date:

2025-05-20

Quarterly Wyeth LLC Patent Applications

Top Inventors for applications by Wyeth LLC

These are the the leading inventors for applications assigned to Wyeth LLC:

Recent patent applications by Wyeth LLC

Wyeth LLC based in Madison, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2023-12-28 ✅ Patent 12,303,592 granted on 2025-05-20
US20230414490A1
Human necessities

Formulations for parenteral delivery of compounds and uses thereof

 #2 | 2022-01-27
US20220023200A1
Human necessities

FORMULATIONS FOR PARENTERAL DELIVERY OF COMPOUNDS AND USES THEREOF

 #3 | 2020-06-11
US20200179270A1
Human necessities

FORMULATIONS FOR PARENTERAL DELIVERY OF COMPOUNDS AND USES THEREOF

 #4 | 2020-05-07 ✅ Patent 11,179,369 granted on 2021-11-23
US20200138781A1
Human necessities

Sustained release pharmaceutical compositions

 #5 | 2020-04-23
US20200121673A1
Human necessities

ORAL FORMULATIONS AND LIPOPHILIC SALTS OF METHYLNALTREXONE

 #6 | 2019-10-17 ✅ Patent 10,507,206 granted on 2019-12-17
US20190314365A1
Human necessities

Oral formulations and lipophilic salts of methylnaltrexone

 #7 | 2019-08-08 ✅ Patent 11,008,373 granted on 2021-05-18
US20190241634A1
Chemistry; metallurgy

Designer osteogenic proteins

 #8 | 2019-04-25 ✅ Patent 10,307,417 granted on 2019-06-04
US20190117646A1
Human necessities

Oral formulations and lipophilic salts of methylnaltrexone

 #9 | 2019-04-25 ✅ Patent 10,376,505 granted on 2019-08-13
US20190117645A1
Human necessities

Oral formulations and lipophilic salts of methylnaltrexone

 #10 | 2018-05-17 ✅ Patent 10,196,433 granted on 2019-02-05
US20180134762A1
Chemistry; metallurgy

Osteogenic proteins

 #11 | 2017-11-09
US20170319711A1
Human necessities

ANTIBODY-DRUG CONJUGATES

 #12 | 2016-11-24 ✅ Patent 10,357,449 granted on 2019-07-23
US20160338946A1
Human necessities

Formulations for parenteral delivery of compounds and uses thereof

 #13 | 2016-11-10
US20160326496A1
Chemistry; metallurgy

TUMOR-INITIATING CELLS AND METHODS FOR USING SAME

 #14 | 2016-07-21 ✅ Patent 9,688,735 granted on 2017-06-27
US20160207973A1
Chemistry; metallurgy

Designer osteogenic proteins

 #15 | 2016-06-23 ✅ Patent 9,738,602 granted on 2017-08-22
US20160176809A1
Chemistry; metallurgy

Processes for making hydrazides

 #16 | 2016-04-28 ✅ Patent 9,492,445 granted on 2016-11-15
US20160113923A1
Human necessities

Peripheral opioid receptor antagonists and uses thereof

 #17 | 2016-03-10 ✅ Patent 9,879,024 granted on 2018-01-30
US20160068540A1
Chemistry; metallurgy

Crystal forms of (R)-N-methylnaltrexone bromide and uses thereof

 #18 | 2015-06-30 ✅ Patent 9,067,981 granted on 2015-06-30
US12608869
Chemistry; metallurgy

Hybrid amyloid-beta antibodies

 #19 | 2015-06-04 ✅ Patent 9,926,368 granted on 2018-03-27
US20150152176A1
Chemistry; metallurgy

Method for treating muscle wasting syndrome using antagonist antibodies against GDF-8

 #20 | 2015-06-04 ✅ Patent 9,180,125 granted on 2015-11-10
US20150150866A1
Human necessities

Peripheral opioid receptor antagonists and uses thereof

 #21 | 2015-04-30 ✅ Patent 9,272,030 granted on 2016-03-01
US20150118223A9
Human necessities

Use of tau to monitor immunotherapy

 #22 | 2015-04-09 ✅ Patent 9,227,924 granted on 2016-01-05
US20150099865A1
Chemistry; metallurgy

Processes for making hydrazides

 #23 | 2015-03-19 ✅ Patent 9,975,683 granted on 2018-05-22
US20150076012A1
Performing operations; transporting

Cap with additive chamber and associated packaging unit

 #24 | 2015-01-22 ✅ Patent 9,505,831 granted on 2016-11-29
US20150024484A1
Chemistry; metallurgy

Isolated cell comprising a nucleic acid encoding antibody inhibitors of gdf-8 and uses thereof

 #25 | 2014-12-11 ✅ Patent 8,999,697 granted on 2015-04-07
US20140363463A1
Chemistry; metallurgy

Shortened purification process for the production of capsular polysaccharides

 #26 | 2014-11-06
US20140328925A1
Human necessities

MICRONIZED TANAPROGET, COMPOSITIONS, AND METHODS OF PREPARING THE SAME

 #27 | 2014-09-04 ✅ Patent 9,314,461 granted on 2016-04-19
US20140249171A1
Human necessities

Oral formulations and lipophilic salts of methylnaltrexone

 #28 | 2014-08-19 ✅ Patent 8,808,707 granted on 2014-08-19
US11740580
-

Pneumococcal dosing regimen

 #29 | 2014-08-14
US20140228389A1
Human necessities

DRY POWDER COMPOUND FORMULATIONS AND USES THEREOF

 #30 | 2014-08-14
US20140228289A1
Chemistry; metallurgy

MODIFIED AND STABILIZED GDF PROPEPTIDES AND USES THEREOF

 #31 | 2014-07-10
US20140194398A1
Human necessities

Tanaproget Compositions Containing Ethinyl Estradiol

 #32 | 2014-07-10
US20140190129A1
Performing operations; transporting

Child Resistant Bulk Dose Dispensing Unit

 #33 | 2014-05-22 ✅ Patent 8,853,232 granted on 2014-10-07
US20140142132A1
Chemistry; metallurgy

Peripheral opioid receptor antagonists and uses thereof

 #34 | 2014-04-24 ✅ Patent 9,279,000 granted on 2016-03-08
US20140113329A1
Chemistry; metallurgy

High-cell density fed-batch fermentation process for producing recombinant protein

 #35 | 2014-04-17 ✅ Patent 9,511,063 granted on 2016-12-06
US20140107147A1
Human necessities

Antineoplastic combinations containing HKI-272 and vinorelbine

 #36 | 2014-04-03
US20140094458A1
Human necessities

Cyclic Progestin Regimens and Kits

 #37 | 2014-03-27 ✅ Patent 8,956,608 granted on 2015-02-17
US20140086920A1
Chemistry; metallurgy

Method for treating sarcopenia using antagonist antibodies against GDF-8

 #38 | 2014-03-20
US20140081010A1
Chemistry; metallurgy

PROCESSES FOR THE CONVERGENT SYNTHESIS OF CALICHEAMICIN DERIVATIVES

 #39 | 2014-03-20
US20140081005A1
Human necessities

ANTIBODY-DRUG CONJUGATES

 #40 | 2014-03-20 ✅ Patent 8,822,490 granted on 2014-09-02
US20140080854A1
Human necessities

Peripheral opioid receptor antagonists and uses thereof

 #41 | 2014-02-20 ✅ Patent 10,729,672 granted on 2020-08-04
US20140050721A1
Human necessities

Antineoplastic combinations with mTOR inhibitor, trastuzumab and/or HKI-272

 #42 | 2014-02-06 ✅ Patent 9,127,050 granted on 2015-09-08
US20140037669A1
Human necessities

Multicomponent immunogenic composition for the prevention of beta-hemolytic streptococcal (BHS) disease

 #43 | 2014-01-16 ✅ Patent 8,927,012 granted on 2015-01-06
US20140017312A1
Human necessities

Multi-vitamin and mineral nutritional supplements

 #44 | 2014-01-16 ✅ Patent 8,889,145 granted on 2014-11-18
US20140017271A1
Human necessities

Immunogenic compositions of antigens

 #45 | 2014-01-02 ✅ Patent 9,211,264 granted on 2015-12-15
US20140004203A1
Human necessities

Coated drug spheroids and uses thereof for eliminating or reducing conditions such as emesis and diarrhea

 #46 | 2014-01-02 ✅ Patent 9,102,680 granted on 2015-08-11
US20140004188A1
Chemistry; metallurgy

Crystal forms of (R)-N-methylnaltrexone bromide and uses thereof

 #47 | 2014-01-02 ✅ Patent 8,790,708 granted on 2014-07-29
US20140004184A1
Human necessities

Coated tablet formulations and uses thereof

 #48 | 2013-12-19
US20130337058A1
Human necessities

Micronized Tanaproget and Compositions Containing Same

 #49 | 2013-12-12 ✅ Patent 8,956,651 granted on 2015-02-17
US20130330407A1
Human necessities

Oral formulations and lipophilic salts of methylnal trexone

 #50 | 2013-12-12 ✅ Patent 8,900,597 granted on 2014-12-02
US20130330371A1
Chemistry; metallurgy

Compositions relating to a mutant toxin and methods thereof

 #51 | 2013-10-24 ✅ Patent 8,772,310 granted on 2014-07-08
US20130281483A1
Chemistry; metallurgy

Peripheral opioid receptor antagonists and uses thereof

 #52 | 2013-10-10 ✅ Patent 9,127,060 granted on 2015-09-08
US20130266594A1
Chemistry; metallurgy

Anti-Notch1 antibodies

 #53 | 2013-09-26 ✅ Patent 8,722,700 granted on 2014-05-13
US20130252998A1
Human necessities

CCI-779 formulations for parenteral administration

 #54 | 2013-09-26 ✅ Patent 8,772,271 granted on 2014-07-08
US20130251807A1
Human necessities

Micronized tanaproget, compositions, and methods of preparing the same

 #55 | 2013-09-19 ✅ Patent 8,557,548 granted on 2013-10-15
US20130244307A1
Chemistry; metallurgy

Compositions relating to a mutant toxin and methods thereof

 #56 | 2013-08-22 ✅ Patent 9,523,092 granted on 2016-12-20
US20130217597A1
Chemistry; metallurgy

Compatible display vector systems

 #57 | 2013-08-15 ✅ Patent 8,853,451 granted on 2014-10-07
US20130211053A1
Chemistry; metallurgy

Processes for making hydrazides

 #58 | 2013-08-15
US20130209501A1
Human necessities

Immunogenic Compositions of Staphylococcus Epidermidis Polypeptide Antigens

 #59 | 2013-08-15 ✅ Patent 9,272,030 granted on 2016-03-01
US20130209453A1
Human necessities

USE OF TAU TO MONITOR IMMUNOTHERAPY

 #60 | 2013-08-01 ✅ Patent 9,822,143 granted on 2017-11-21
US20130197198A1
Chemistry; metallurgy

Removal of high molecular weight aggregates using hydroxyapatite chromatography

 #61 | 2013-08-01 ✅ Patent 8,987,205 granted on 2015-03-24
US20130196930A1
Chemistry; metallurgy

Polynucleotides encoding recombinant lubricin molecules and uses thereof

 #62 | 2013-07-04 ✅ Patent 9,556,240 granted on 2017-01-31
US20130171194A1
Chemistry; metallurgy

Stable formulations of rLP2086 antigens

 #63 | 2013-06-20 ✅ Patent 8,496,934 granted on 2013-07-30
US20130156767A1
Chemistry; metallurgy

Method for treating cachexia using antagonist antibodies against GDF-8

 #64 | 2013-06-13
US20130150554A1
Chemistry; metallurgy

CELL CULTURE OF GROWTH FACTOR-FREE ADAPTED CELLS

 #65 | 2013-06-06
US20130143827A1
Chemistry; metallurgy

TANAPROGET DERIVATIVES, METABOLITES, AND USES THEREOF

 #66 | 2013-06-06 ✅ Patent 8,791,109 granted on 2014-07-29
US20130142838A1
Human necessities

Compositions containing micronized tanaproget prepared by wet granulation

 #67 | 2013-05-09
US20130116327A1
Human necessities

Burst Drug Release Compositions

 #68 | 2013-05-09
US20130115250A1
Human necessities

Burst Drug Release Compositions

 #69 | 2013-05-02 ✅ Patent 8,575,159 granted on 2013-11-05
US20130109670A1
Chemistry; metallurgy

Triazine compounds as PI3 kinase and mTOR inhibitors

 #70 | 2013-04-04
US20130084593A1
Chemistry; metallurgy

RATIONALLY DESIGNED MEDIA FOR CELL CULTURE

 #71 | 2013-04-04
US20130084245A1
Human necessities

PET MONITORING OF A-BETA-DIRECTED IMMUNOTHERAPY

 #72 | 2013-03-21 ✅ Patent 9,095,567 granted on 2015-08-04
US20130072881A1
Human necessities

Vaccine formulations

 #73 | 2013-03-21 ✅ Patent 8,466,146 granted on 2013-06-18
US20130072480A1
Chemistry; metallurgy

Cyclothiocarbamate derivatives as progesterone receptor modulators

 #74 | 2013-03-14
US20130065928A1
Physics

BIOMARKERS FOR PI3K-DRIVEN CANCER

 #75 | 2013-02-14 ✅ Patent 8,455,539 granted on 2013-06-04
US20130040980A1
Human necessities

CCI-779 concentrate formulations

 #76 | 2013-02-07 ✅ Patent 8,562,999 granted on 2013-10-22
US20130034580A1
Human necessities

Formulations which stabilize and inhibit precipitation of immunogenic compositions

 #77 | 2013-01-24 ✅ Patent 8,647,638 granted on 2014-02-11
US20130023032A1
Chemistry; metallurgy

Synergistic attenuation of vesicular stomatitis virus, vectors thereof and immunogenic compositions thereof

 #78 | 2013-01-24
US20130022547A1
Chemistry; metallurgy

ATTENUATED MYCOPLASMA GALLISEPTICUM STRAINS

 #79 | 2013-01-17 ✅ Patent 8,618,284 granted on 2013-12-31
US20130018184A1
Chemistry; metallurgy

Methods of preparing polymorphic form A of bazedoxifene acetate

 #80 | 2013-01-17 ✅ Patent 8,546,549 granted on 2013-10-01
US20130018179A1
Chemistry; metallurgy

Processes for the convergent synthesis of calicheamicin derivatives

 #81 | 2013-01-10 ✅ Patent 8,609,712 granted on 2013-12-17
US20130012702A1
Chemistry; metallurgy

Purification of progesterone receptor modulators

 #82 | 2013-01-10 ✅ Patent 8,586,049 granted on 2013-11-19
US20130011418A1
Human necessities

Antibody-drug conjugates

 #83 | 2013-01-03 ✅ Patent 8,445,486 granted on 2013-05-21
US20130005723A1
Chemistry; metallurgy

Triazine compounds as PI3 kinase and mTOR inhibitors

 #84 | 2013-01-03 ✅ Patent 8,470,993 granted on 2013-06-25
US20130005033A1
Chemistry; metallurgy

Nucleic acid encoding antibody to human IL-22

 #85 | 2012-12-20
US20120322104A1
Chemistry; metallurgy

SYSTEMS AND METHODS FOR PROTEIN PRODUCTION

 #86 | 2012-12-06
US20120308560A1
Human necessities

Antineoplastic Combinations with mTOR Inhibitor, Trastuzumab and/or HKI-272

 #87 | 2012-12-06 ✅ Patent 8,883,849 granted on 2014-11-11
US20120308483A1
Human necessities

Treatment of sleep disturbances

 #88 | 2012-11-22 ✅ Patent 9,420,819 granted on 2016-08-23
US20120294983A1
Human necessities

Nutritional formulation

 #89 | 2012-11-15 ✅ Patent 8,394,959 granted on 2013-03-12
US20120289545A1
Chemistry; metallurgy

Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl)-4-(dimethylamino)-2-buteramide and crystalline forms thereof

 #90 | 2012-11-08
US20120282248A1
Chemistry; metallurgy

PREVENTION AND TREATMENT OF CEREBRAL AMYLOID ANGIOPATHY

 #91 | 2012-11-01 ✅ Patent 9,125,951 granted on 2015-09-08
US20120276137A1
Human necessities

Compositions and methods for preparing serotype 5 and 8 capsular polysaccharide conjugate immunogenic compositions

 #92 | 2012-11-01
US20120276102A1
Physics

METHODS OF TREATMENT UTILIZIING BINDING PROTEINS OF THE INTERLEUKIN-21 RECEPTOR

 #93 | 2012-10-25
US20120270896A1
Human necessities

Antineoplastic Combinations Containing HKI-272 and Vinorelbine

 #94 | 2012-10-25 ✅ Patent 8,481,692 granted on 2013-07-09
US20120269841A1
Chemistry; metallurgy

Compositions relating to a mutant toxin and methods thereof

 #95 | 2012-10-18
US20120264919A1
Chemistry; metallurgy

INTERLEUKIN-21 RECEPTOR BINDING PROTEINS

 #96 | 2012-10-04 ✅ Patent 8,710,025 granted on 2014-04-29
US20120252884A1
Chemistry; metallurgy

Modified and stabilized GDF propeptides and uses thereof

 #97 | 2012-10-04 ✅ Patent 8,815,934 granted on 2014-08-26
US20120252769A1
Human necessities

2-Phenyl-1-[4-(2-Aminoethoxy)-Benzyl]-Indole and estrogen formulations

 #98 | 2012-10-04 ✅ Patent 8,309,094 granted on 2012-11-13
US20120251558A1
Human necessities

Antibody-drug conjugates

 #99 | 2012-09-27
US20120244113A1
Chemistry; metallurgy

IMMUNOGENIC COMPOSITION AND METHODS

 #100 | 2012-09-20 ✅ Patent 8,808,708 granted on 2014-08-19
US20120237542A1
Human necessities

Multivalent pneumococcal polysaccharide-protein conjugate composition

Also check out Wyeth LLC's (Madison, United States) applicant profile with 44 patent applications submitted.

AssigneeID:

1745 ⎘